Found 1 results
Filters: Keyword is Drug Repositioning  [Clear All Filters]
2021
Duarte RRR, Copertino DC, IƱiguez LP, Marston JL, Bram Y, Han Y, Schwartz RE, Chen S, Nixon DF, Powell TR.  2021.  Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.. Mol Med. 27(1):105.